Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.
 

The Analysis of Pyridyloxobutyl RNA Adducts in Rats Treated With 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone

2009-04-08
Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

The Analysis of Pyridyloxobutyl RNA Adducts in Rats Treated With 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone

Published Date

2009-04-08

Publisher

Type

Presentation

Abstract

Tobacco-specific nitrosamines are potent carcinogens formed from parent compounds such as nicotine during the curing process of tobacco. The cytochrome P450 enzyme family metabolically activates these nitrosamines, which then attach pyridyloxobutyl (POB) groups to DNA bases. The formation of POB-DNA adducts in tissues of rats treated with tobacco-specific nitrosamines have been demonstrated in previous studies. These adducts can potentially lead to mutations in DNA which promote the formation of tumors. However there exists no data on the formation of POB-RNA adducts. RNA adducts could be important in carcinogenesis, and could potentially be a more reliable biomarker than DNA adducts for tobacco-specific nitrosamine exposure. The objective of our project was to chemically characterize and quantify POB-RNA adducts in the tissue of rats treated with a nitrosamine compound, specifically 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). RNA was isolated from rat liver treated with NNK over a course of 20 weeks and from untreated liver. Combined liquid chromatography-mass spectrometry and high performance liquid chromatography were used to identify RNA adducts. The results indicate the presence of POB-RNA adducts in the treated livers. Further work will involve synthesizing standards by reacting NNK with nucleosides and confirming the structure of adducts with NMR. The results of this study will confirm the presence of RNA adducts due to nitrosamine exposure and provide insight into the utility of RNA adducts as a biomarker used for chemopreventative strategies.

Description

Additional contributors: Irina Stepanov; Stephen Hecht (faculty mentor).

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Muzic, John. (2009). The Analysis of Pyridyloxobutyl RNA Adducts in Rats Treated With 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/50348.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.